phenylephrine has been researched along with Cirrhoses, Experimental Liver in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (38.89) | 18.2507 |
2000's | 8 (44.44) | 29.6817 |
2010's | 3 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdollahi, A; Dehpour, AR; Eftekhari, G; Ejtemaei-Mehr, S; Jazaeri, F; Nikoui, V; Ostadhadi, S; Rezayat, SM; Tavangar, SM | 1 |
Bolognesi, M; Di Pascoli, M; Gatta, A; Merkel, C; Quarta, S; Sacerdoti, D; Zampieri, F | 1 |
Bolognesi, M; Gaiani, S; Gatta, A; Jiang, H; McGiff, JC; Sacerdoti, D | 1 |
Avsar, FM; Iskit, AB; Ozel, H; Tanriverdi, P; Topaloglu, S; Yuksel, BC | 1 |
Angeli, P; Bolognesi, M; Di Pascoli, M; Gatta, A; Merkel, C; Pontisso, P; Quarta, S; Sacerdoti, D; Sticca, A | 1 |
Ghali-Ghoul, R; Lugnier, C; Sabra, R; Tahseldar-Roumieh, R | 1 |
Fukui, H; Kojima, H; Sakurai, S; Satoh, H; Uemura, M | 1 |
Alcaraz, A; Atucha, NM; García-Estañ, J; Iyú, D; Ortiz, MC | 1 |
Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lee, TY; Lin, HC; Wang, YW; Yang, YY | 1 |
Gines, P; Higa, EM; Martin, PY; McMurtry, IF; Niederberger, M; Schrier, RW; Weigert, AL | 1 |
Gaudin, C; Hartleb, M; Lebrec, D; Moreau, R | 1 |
Blaise, G; Chen, H; Leonard, V; Van Obbergh, L; Xu, D | 1 |
Chabot, F; Dall'Ava-Santucci, J; Dinh-Xuan, AT; Lockhart, A; Mestiri, H; Sabry, S | 1 |
Atucha, NM; Fortepiani, LA; García-Estañ, J; Martínez, C; Ortíz, MC | 1 |
Martin, PY; Schrier, RW; Weigert, AL | 1 |
Cales, P; Heller, J; Lebrec, D; Lefilliatre, P; Moreau, R; Oberti, F; Pateron, D; Poirel, O; Sogni, P; Tazi, KA; Veal, N | 1 |
Heller, J; Lebrec, D; Moreau, R; Poirel, O; Tazi, KA | 1 |
Fleming, I; Folz, IC; Hanisch, EW; Holzer, K; Kimpel, M; Schmandra, TC | 1 |
18 other study(ies) available for phenylephrine and Cirrhoses, Experimental Liver
Article | Year |
---|---|
Mesenteric artery responsiveness to acetylcholine and phenylephrine in cirrhotic rats challenged with endotoxin: the role of TLR4.
Topics: Acetylcholine; Animals; Bile Ducts; Endothelium; Endotoxemia; Endotoxins; Ligation; Lipopolysaccharides; Liver Cirrhosis, Experimental; Male; Mesenteric Arteries; Myocytes, Smooth Muscle; Phenylephrine; Rats; Rats, Wistar; Toll-Like Receptor 4; Vasoconstriction; Vasodilation | 2015 |
Heme oxygenase regulates renal arterial resistance and sodium excretion in cirrhotic rats.
Topics: Acetylcholine; Animals; Blotting, Western; Carbon Monoxide; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Liver Cirrhosis, Experimental; Male; Mesoporphyrins; Phenylephrine; Rats; Rats, Wistar; Renal Artery; Sodium; Vascular Resistance | 2011 |
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Carbon Tetrachloride; Cytochrome P-450 Enzyme System; Endothelin-1; Hepatic Veins; Hydroxyeicosatetraenoic Acids; Hypertension, Portal; Infusion Pumps; Liver; Liver Cirrhosis, Experimental; Male; Miconazole; Organ Culture Techniques; Oxidoreductases; Phenylephrine; Portal Pressure; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstriction; Vasodilation | 2011 |
The effects of nitric oxide synthase blockers on mesenteric blood flow with bile duct ligation.
Topics: Animals; Bile Ducts; Blood Pressure; Enzyme Inhibitors; Female; Hemodynamics; Jaundice, Obstructive; Ligation; Liver Cirrhosis, Experimental; Mesenteric Artery, Superior; Nitric Oxide Synthase; Nitroarginine; Phenylephrine; Random Allocation; Rats; Rats, Wistar; Regional Blood Flow; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2003 |
Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites.
Topics: Animals; Ascites; Blotting, Western; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Liver Cirrhosis, Experimental; Male; Mesenteric Arteries; Mesoporphyrins; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenylephrine; Rats; Rats, Inbred WKY; Tissue Culture Techniques; Vasoconstriction; Vasoconstrictor Agents | 2005 |
Effect of phosphodiesterase 5 inhibitor on alteration in vascular smooth muscle sensitivity and renal function in rats with liver cirrhosis.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Allopurinol; Animals; Bile Ducts; Cyclic Nucleotide Phosphodiesterases, Type 5; Diazoxide; Hemodynamics; Kidney; Kidney Function Tests; Ligation; Liver Cirrhosis, Experimental; Muscle, Smooth, Vascular; Nitroglycerin; Penicillamine; Phenylephrine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rats; Rats, Sprague-Dawley; Vasodilation | 2006 |
Local regulator adrenomedullin contributes to the circulatory disturbance in cirrhotic rats.
Topics: Adrenomedullin; Animals; Blood Pressure; Cardiac Output, High; Hypotension; Liver Cirrhosis, Experimental; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptides; Phenylephrine; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstriction | 2006 |
Vitamin E supplementation reverses renal altered vascular reactivity in chronic bile duct-ligated rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Bile Ducts; Chronic Disease; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Kidney; Ligation; Liver Cirrhosis, Experimental; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Nitroprusside; Perfusion; Phenylephrine; Random Allocation; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Vasoconstrictor Agents; Vasodilator Agents; Vitamin E | 2007 |
Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
Topics: Acetylcholine; Animals; Apamin; Arachidonic Acids; Cannabinoid Receptor Modulators; Charybdotoxin; Common Bile Duct; Dose-Response Relationship, Drug; Endocannabinoids; Glyburide; Ligation; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Male; Mesenteric Artery, Superior; Nitroprusside; Peptides; Phenylephrine; Piperidines; Polyunsaturated Alkamides; Potassium; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Potassium Chloride; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2007 |
Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats.
Topics: Animals; Aorta; Arginine; Blotting, Northern; Carbon Tetrachloride; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Gene Expression; Lipopolysaccharides; Liver Cirrhosis, Experimental; Male; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenylephrine; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1995 |
Lack of vascular hyporesponsiveness to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Blood Vessels; Calcium Channels; Dose-Response Relationship, Drug; Ganglionic Blockers; Liver Cirrhosis, Experimental; Male; Phenylephrine; Rats; Rats, Sprague-Dawley; Vasopressins | 1995 |
The endothelial and non-endothelial mechanism responsible for attenuated vasoconstriction in cirrhotic rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Vessels; Cyclooxygenase Inhibitors; Endothelium, Vascular; Liver Cirrhosis, Experimental; Male; Nitric Oxide Synthase; Phenylephrine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1995 |
Role of NO in the pulmonary artery hyporeactivity to phenylephrine in experimental biliary cirrhosis.
Topics: Acetylcholine; Animals; Arginine; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; Nitroprusside; Phenylephrine; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasoconstrictor Agents | 1996 |
Vascular hyporesponsiveness in aortic rings from cirrhotic rats: role of nitric oxide and endothelium.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Culture Techniques; Dose-Response Relationship, Drug; Endothelium, Vascular; Liver Cirrhosis, Experimental; Male; Nitric Oxide; Phenylephrine; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasodilation | 1996 |
Vascular hyporesponsiveness in cirrhotic rats: role of different nitric oxide synthase isoforms.
Topics: Animals; Aorta; Blotting, Northern; Blotting, Western; Enzyme Induction; In Vitro Techniques; Isoenzymes; Liver Cirrhosis, Experimental; Male; Nitric Oxide Synthase; Phenylephrine; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 1997 |
Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis.
Topics: Animals; Aorta, Thoracic; Carotid Arteries; Culture Techniques; Hemodynamics; Liver Cirrhosis, Experimental; Male; Mesenteric Artery, Superior; Phenylephrine; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Changes in protein kinase C isoforms in association with vascular hyporeactivity in cirrhotic rat aortas.
Topics: Animals; Aorta; Biological Transport; Down-Regulation; Intracellular Membranes; Isoenzymes; Liver Cirrhosis, Experimental; Male; Phenylephrine; Protein Kinase C; Rats; Rats, Sprague-Dawley; Reference Values; Tetradecanoylphorbol Acetate; Time Factors; Tissue Distribution; Vasoconstriction; Vasoconstrictor Agents; Vasomotor System | 2000 |
Cirrhosis serum induces a nitric oxide-associated vascular hyporeactivity of aortic segments from healthy rats in vitro.
Topics: Animals; Aorta; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidines; In Vitro Techniques; Liver Cirrhosis, Experimental; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroarginine; Phenylephrine; Rats; Rats, Sprague-Dawley; Sulfonamides; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2001 |